Drug Interaction Report

Somatrogon-Ghla and Fluocinolone Topical: Interaction Details

AI-assisted, pharmacist-reviewed · Source data updated Aug 8, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature

Fluocinolone Topical

Capex® Shampoo Derma-Smoothe/FS® Fluocet® Fluonid® Fluotrex® Neo-Synalar® (as a combination product containing Fluocinolone and Neomycin) Synalar Synalar®
+

Somatrogon-Ghla

No brand names on record
Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by
Updated Aug 8, 2026
LinkedIn
Interaction severity
Major
Potentially serious — often needs a change or close monitoring.
How we grade severity & evidence

Severity levels

  • Contraindicated: These should generally not be used together.
  • Major: Potentially serious — often needs a change or close monitoring.
  • Moderate: Can be significant — usually manageable with monitoring.
  • Minor: Usually limited clinical impact.

Evidence grades

  • Established: Well documented — supported by controlled studies or strong clinical data.
  • Probable: Good supporting evidence, though not definitively proven.
  • Suspected: Some evidence suggests this interaction, but it is not well established.
  • Possible: Limited or conflicting evidence; the interaction may occur.
  • Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Of 58 documented Somatrogon-Ghla interactions, 58 are rated major — including this one.
Worried about symptoms right now? Contact your pharmacist or prescriber, or call Poison Control at 1-800-222-1222 (US). Call 911 for an emergency.
Onset
unspecified
Evidence
theoretical
Severity
Major

What happens

Reduced serum cortisol exposure, an increased risk of central (secondary) hypoadrenalism and attenuated growth-promoting effects of somatrogon-ghla

Interaction Deep Dive

Patients being treated with glucocorticoids replacement for previously diagnosed hypoadrenalism may require an increase in their maintenance or stress doses when receiving concomitant somatrogon-ghla therapy. Somatrogon-ghla inhibits 11-beta-hydroxysteroid dehydrogenase type 1, and conversion of cortisone to its active metabolite, cortisol, in hepatic and adipose tissue. Consequently, individuals with untreated growth hormone deficiency have relative increases in 11-beta-hydroxysteroid dehydrogenase type 1 and serum cortisol. Initiation of somatrogon-ghla may result in inhibition of 11-beta-hydroxysteroid dehydrogenase type 1 and reduced serum cortisol concentrations. Cortisone acetate and predniSONE may be affected more than others because conversion of these drugs to their biologically active metabolites is dependent on the activity of 11-beta-hydroxysteroid dehydrogenase type 1. In children, concomitant administration glucocorticoids and somatrogon-ghla may reduce the growth-promoting activity of somatrogon-ghla. Carefully adjust the glucocorticoid replacement dosing to avoid both hypoadrenalism and an inhibitory effect on growth1.

Why it happens (mechanism)

Inhibition of 11-beta-hydroxysteroid dehydrogenase type 1 in hepatic and adipose tissue; attenuation of growth-promoting effects of somatrogon-ghla

Common questions

Can I take Somatrogon-Ghla and Fluocinolone Topical together?

Reduced serum cortisol exposure, an increased risk of central (secondary) hypoadrenalism and attenuated growth-promoting effects of somatrogon-ghla Always confirm with your pharmacist or prescriber before making any change.

How serious is the Somatrogon-Ghla and Fluocinolone Topical interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How strong is the evidence for this interaction?

The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.

Questions for your pharmacist

  • Does my dose of Somatrogon-Ghla or Fluocinolone Topical need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there a safer alternative to one of these medications for me?

References (1)

  1. Product Information: NGENLA subcutaneous solution, somatrogon-ghla subcutaneous solution. Pfizer Labs (per FDA), New York, NY, 2023. DailyMed
Was this write-up helpful?
Beyond drug–drug

These medications also interact with supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

major · moderate · minor — check everything you take with our drug–supplement interaction checker.

Check another combination

Our instant two-drug interaction checker is almost here.

Coming soon

The instant two-drug checker is on its way.

In the meantime, browse the directory below to look up any drug and see its documented interactions.

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.